George Bozas
George Bozas
Queen's Centre for Oncology and Haematology, Castle Hill Hospital, Cottingham UK
Verified email at
Cited by
Cited by
Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors
A Bamias, E Kastritis, C Bamia, LA Moulopoulos, I Melakopoulos, ...
J Clin Oncol 23 (34), 8580-7, 2005
Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer
A Maraveyas, J Waters, R Roy, D Fyfe, D Propper, F Lofts, J Sgouros, ...
European journal of cancer 48 (9), 1283-1292, 2012
Risk of recurrent venous thromboembolism and major hemorrhage in cancer‐associated incidental pulmonary embolism among treated and untreated patients: a pooled analysis of 926 …
T Hulle, PL Exter, B Planquette, G Meyer, S Soler, M Monreal, D Jiménez, ...
Journal of Thrombosis and Haemostasis 14 (1), 105-113, 2016
Efficacy of reduced-intensity chemotherapy with oxaliplatin and capecitabine on quality of life and cancer control among older and frail patients with advanced gastroesophageal …
PS Hall, D Swinson, DA Cairns, JS Waters, R Petty, C Allmark, S Ruddock, ...
JAMA oncology 7 (6), 869-877, 2021
The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy
A Bamias, E Efstathiou, LA Moulopoulos, D Gika, G Hamilos, MP Zorzou, ...
Annals of oncology 16 (2), 307-313, 2005
The Khorana score for prediction of venous thromboembolism in cancer patients: an individual patient data meta‐analysis
N van Es, M Ventresca, M Di Nisio, Q Zhou, S Noble, M Crowther, M Briel, ...
Journal of thrombosis and haemostasis 18 (8), 1940-1951, 2020
The risk of venous thromboembolism associated with peripherally inserted central catheters in ambulant cancer patients
D Jones, K Wismayer, G Bozas, J Palmer, M Elliott, A Maraveyas
Thrombosis journal 15, 1-6, 2017
Endometrial cancer: what is new in adjuvant and molecularly targeted therapy?
F Zagouri, G Bozas, E Kafantari, M Tsiatas, N Nikitas, MA Dimopoulos, ...
Obstetrics and gynecology international 2010, 2010
Osteonecrosis of the jaw after a single bisphosphonate infusion in a patient with metastatic renal cancer treated with sunitinib
G Bozas, A Roy, V Ramasamy, A Maraveyas
Oncology Research and Treatment 33 (6), 321-323, 2010
Clinicopathological features of ovarian carcinosarcomas: a single institution experience
MP Zorzou, S Markaki, A Rodolakis, E Kastritis, G Bozas, MA Dimopoulos, ...
Gynecologic oncology 96 (1), 136-142, 2005
The outcome of advanced or recurrent non-squamous carcinoma of the uterine cervix after platinum-based combination chemotherapy
E Kastritis, A Bamias, E Efstathiou, D Gika, G Bozas, P Zorzou, K Sarris, ...
Gynecologic oncology 99 (2), 376-382, 2005
Developments in the systemic treatment of endometrial cancer
G Mountzios, D Pectasides, E Bournakis, E Pectasides, G Bozas, ...
Critical reviews in oncology/hematology 79 (3), 278-292, 2011
Brain metastases as isolated site of relapse in patients with epithelial ovarian cancer previously treated with platinum and paclitaxel-based chemotherapy
E Kastritis, E Efstathiou, D Gika, G Bozas, V Koutsoukou, C Papadimitriou, ...
International Journal of Gynecologic Cancer 16 (3), 2006
The Incidence of Osteonecrosis of the Jaw (ONJ) in Patients with Multiple Myeloma Who Receive Biphosphonates Depends on the Type of Biphosphonate.
MA Dimopoulos, E Kastritis, LA Moulopoulos, I Melakopoulos, ...
Blood 106 (11), 637, 2005
The impact of age in the outcome of patients with advanced or recurrent cervical cancer after platinum-based chemotherapy
E Kastritis, A Bamias, G Bozas, V Koutsoukou, Z Voulgaris, G Vlahos, ...
Gynecologic oncology 104 (2), 372-376, 2007
Biweekly gemcitabine and cisplatin in platinum-resistant/refractory, paclitaxel-pretreated, ovarian and peritoneal carcinoma
G Bozas, A Bamias, V Koutsoukou, E Efstathiou, D Gika, ...
Gynecologic oncology 104 (3), 580-585, 2007
Combination of docetaxel, estramustine phosphate, and zoledronic acid in androgen-independent metastatic prostate cancer: efficacy, safety, and clinical benefit assessment
E Efstathiou, G Bozas, A Kostakopoulos, E Kastritis, C Deliveliotis, ...
Urology 65 (1), 126-130, 2005
Young age is associated with favorable characteristics but is not an independent prognostic factor in patients with epithelial ovarian cancer: a single institution experience
G Bozas, MA Dimopoulos, E Kastritis, E Efstathiou, V Koutsoukou, ...
Oncology 70 (4), 265-272, 2006
Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis
HJ Schünemann, M Ventresca, M Crowther, M Briel, Q Zhou, S Noble, ...
The Lancet Haematology 7 (10), e746-e755, 2020
Prognostic and predictive factors in patients with androgen-independent prostate cancer treated with docetaxel and estramustine: a single institution experience
A Bamias, G Bozas, N Antoniou, I Poulias, H Katsifotis, A Skolarikos, ...
European urology 53 (2), 323-332, 2008
The system can't perform the operation now. Try again later.
Articles 1–20